Press "Enter" to skip to content

Serum Institute to resume India trial of AstraZeneca's COVID-19 vaccine -report

BENGALURU (Reuters) – India’s drugs regulator has given approval to Serum Institute of India to…
Read More

The Star : News Feed

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: